• Citer

Prostate lineage-specific metabolism governs luminal differentiation and response to antiandrogen treatment.

par Giafaglione, Jenna JM;Crowell, Preston PD;Delcourt, Amelie M L;Hashimoto, Takao;Ha, Sung Min;Atmakuri, Aishwarya;Nunley, Nicholas NM;Dang, Rachel M A;Tian, Mao;Diaz, Johnny A;Tika, Elisavet ;Payne, Marie C;Burkhart, Deborah DL;Li, Dong;Navone, Nora NM;Corey, Eva;Nelson, Peter S;Lin, Neil Y C;Blanpain, Cédric ;Ellis, Leigh;Boutros, Paul C;Goldstein, Andrew S
Référence Nature cell biology, 25, 12, page (1821-1832)
Publication Publié, 2023-12-01

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Résumé :

Lineage transitions are a central feature of prostate development, tumourigenesis and treatment resistance. While epigenetic changes are well known to drive prostate lineage transitions, it remains unclear how upstream metabolic signalling contributes to the regulation of prostate epithelial identity. To fill this gap, we developed an approach to perform metabolomics on primary prostate epithelial cells. Using this approach, we discovered that the basal and luminal cells of the prostate exhibit distinct metabolomes and nutrient utilization patterns. Furthermore, basal-to-luminal differentiation is accompanied by increased pyruvate oxidation. We establish the mitochondrial pyruvate carrier and subsequent lactate accumulation as regulators of prostate luminal identity. Inhibition of the mitochondrial pyruvate carrier or supplementation with exogenous lactate results in large-scale chromatin remodelling, influencing both lineage-specific transcription factors and response to antiandrogen treatment. These results establish reciprocal regulation of metabolism and prostate epithelial lineage identity.